Chemotherapy in biliary tract carcinomas: Results in India

Seminars in Oncology

Volumn 29, Issue 6 SUPPL. 20, 2002, Pages 46-50

  Doval, Dinesh C ^a   Sekhon, Jagdev S ^b   Gupta, Sunil K ^b   Gupta, Sanjay ^b   Awasthy, Bhawana S ^b  

^a RAJIV GANDHI CANCER INSTITUTE AND RESEARCH CENTRE   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; GEMCITABINE;

ADVANCED CANCER; ANEMIA; BILE DUCT CARCINOMA; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SCREENING; DRUG TOXICITY; FEBRILE NEUTROPENIA; FEMALE; GERIATRIC DISORDER; GRANULOCYTOPENIA; HUMAN; LEUKOPENIA; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; POPULATION; PRIORITY JOURNAL; SYMPTOM; THROMBOCYTOPENIA;

EID: 0036991814     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2002.37375     Document Type: Conference Paper

References (20)

1. Ahlgren JD: Neoplasms of the hepatobiliary systems, in Calabresi P, Schein PS (eds): Medical Oncology 2. New York, NY, McGraw-Hill, 1993, pp 713-739
2. De Groen PC, Gores GJ, LaRusso NF, et al: Biliary tract cancers. N Engl J Med 341:1368-1378, 1999
3. National Cancer Registry Programme: Consolidated Report of Population Based Cancer Registries: 1990-1996, Indian Council of Medical Research, August, 2001. Available at: http://icmr.nic.in/cancer_reg.pdf (accessed)
4. Dwivedi M, Misra SP, Misra V: Clinical and ultrasonographic findings of carcinoma of the gallbladder in Indian patients. J Assoc Physicians India 48:192-195, 2000
5. Gupta SC, Misra V, Singh PA, et al: Gallstones and carcinoma gallbladder. Ind J Pathol Microbiol 43:147-154, 2000
6. Pandey M, Khatri AK, Dubey SS, et al: Erythrocyte membrane fatty acid profile in patients with primary carcinoma of the gallbladder. J Surg Oncol 59:31-34, 1995
7. Shukla VK, Shukla PK, Pandey M, et al: Lipid peroxidation product in bile from patients with carcinoma of the gall-bladder: A preliminary study. J Surg Oncol 56:258-262, 1994
8. Misra S, Chaturvedi A, Goel MM, et al: Over expression of p53 protein in gallbladder carcinoma in North India. Eur J Surg Oncol 26:164-167, 2000
9. Hejna M, Pruckmayer M, Raderer M: The role of chemotherapy and radiation in the management of biliary cancer: A review of the literature. Eur J Cancer 34:977-986, 1998
10. Eckel F, Lersch C, Assmann G, et al: Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer. Ann Oncol 11:762-763, 2000
11. Doval DC, Sekhon JS, Fuloria J, et al: Gemcitabine and cisplatin in chemotherapy naïve, unresectable gallbladder cancer: A large multicenter, phase II study. Proc Am Soc Clin Oncol 20:156a, 2001 (abstr 622)
12. Arroyo-G, Gallardo J, Rubio B, et al: Gemcitabine (GEM) in advanced biliary tract cancer (ABTC) experience from Chile and Argentina in phase II trials. Proc Am Soc Clin Oncol 20:157a, 2001 (abstr 626)
13. Penz M, Kornek G, Radere M, et al: Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 12:183-186, 2001
14. Falkson G, Macintyre JM, Moertel CG: Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 54:965-969, 1984
15. Harvey JH, Smith FP, Schein PS: 5-fluorouracil, mitomycin and doxorubicin (FAM) in carcinoma of the biliary tract. J Clin Oncol 2:1245-1248, 1984
16. Taal BG, Audisio RA, Bleiberg H, et al: Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cooperative Group study. Ann Oncol 4:607-609, 1993
17. Okada S, Ishii, Nose H, et al: A phase II study of cisplatin in patients with biliary tract carcinoma. Oncology 51:515-517, 1994
18. Kajanti M, Pyrhonen S: Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study. Am J Clin Oncol 17:223-226, 1994
19. Takada F, Kato H, Matsushiro T, et al: Comparison of 5-fluorouracil, doxorubicin, and mitomycin C with 5-fluorouracil alone in treatment of pancreatic-biliary carcinomas. Oncology 51:396-400, 1994
20. Sekhon JS, Pannu HS, Singh H, et al: A phase II trial of weekly 5-fluorouracil and leucovorin in unresectable and metastatic gallbladder cancer. Int J Cancer Suppl 13:233, 2002 (abstr 290)